Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cervical Cancer

  Free Subscription


10.04.2017

1 Acta Obstet Gynecol Scand
1 BMJ Open
1 Cancer Med
1 Cell Mol Biol (Noisy-le-grand)
1 Chin J Cancer Res
2 Cytogenet Genome Res
1 Cytopathology
4 Drug Deliv
1 Eur J Cancer Prev
1 Health Policy Plan
1 Indian J Dermatol Venereol Leprol
1 Int J Biol Markers
1 Int J Cancer
1 Int J Oncol
2 J BUON
1 J Cancer
1 J Cancer Educ
1 J Clin Diagn Res
2 J Gynecol Oncol
1 J Natl Cancer Inst
1 J Obstet Gynaecol Res
1 Keio J Med
2 Med J Aust
1 Microbiol Immunol
1 Mol Med Rep
1 Pathol Res Pract
1 Pathology
2 PLoS One
1 Radiother Oncol
1 Reprod Sci
1 Sci Rep
1 Singapore Med J
2 Tumour Biol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Obstet Gynecol Scand

  1. MUNRO A, Codde J, Spilsbury K, Stewart CJ, et al
    Risk of persistent or recurrent neoplasia in conservatively treated women with cervical adenocarcinoma in situ with negative histological margins.
    Acta Obstet Gynecol Scand. 2017;96:432-437.
    PubMed     Text format     Abstract available


    BMJ Open

  2. CHANG HK, Myong JP, Byun SW, Lee SJ, et al
    Factors associated with participation in cervical cancer screening among young Koreans: a nationwide cross-sectional study.
    BMJ Open. 2017;7:e013868.
    PubMed     Text format     Abstract available


    Cancer Med

  3. WU Q, Zhao X, Fu Y, Wang X, et al
    A cross-sectional study on HPV testing with type 16/18 genotyping for cervical cancer screening in 11,064 Chinese women.
    Cancer Med. 2017 Apr 4. doi: 10.1002/cam4.1060.
    PubMed     Text format     Abstract available


    Cell Mol Biol (Noisy-le-grand)

  4. LIU Y, Zhang L, Zhao G, Che L, et al
    The clinical research of Thinprep Cytology Test (TCT) combined with HPV-DNA detection in screening cervical cancer.
    Cell Mol Biol (Noisy-le-grand). 2017;63:92-95.
    PubMed     Text format     Abstract available


    Chin J Cancer Res

  5. LIU C, Wang J, Hu Y, Xie H, et al
    Upregulation of kazrin F by miR-186 suppresses apoptosis but promotes epithelial-mesenchymal transition to contribute to malignancy in human cervical cancer cells.
    Chin J Cancer Res. 2017;29:45-56.
    PubMed     Text format     Abstract available


    Cytogenet Genome Res

  6. GAO G, Smith DI
    Human Papillomavirus and the Development of Different Cancers.
    Cytogenet Genome Res. 2016;150.
    PubMed     Text format     Abstract available

  7. GAO G, Smith DI
    Role of the Common Fragile Sites in Cancers with a Human Papillomavirus Etiology.
    Cytogenet Genome Res. 2016;150.
    PubMed     Text format     Abstract available


    Cytopathology

  8. MUNAKATA S, Sasaki S, Takase M, Okatake R, et al
    Practical usefulness of atypical endometrial cell categories within the new classification of endometrial cytology when applied to conventional smears.
    Cytopathology. 2017;28:131-139.
    PubMed     Text format     Abstract available


    Drug Deliv

  9. HUA X, Yang Q, Dong Z, Zhang J, et al
    Magnetically triggered drug release from nanoparticles and its applications in anti-tumor treatment.
    Drug Deliv. 2017;24:511-518.
    PubMed     Text format     Abstract available

  10. SCRIVANO L, Iacopetta D, Sinicropi MS, Saturnino C, et al
    Synthesis of sericin-based conjugates by click chemistry: enhancement of sunitinib bioavailability and cell membrane permeation.
    Drug Deliv. 2017;24:482-490.
    PubMed     Text format     Abstract available

  11. WU S, Yang X, Lu Y, Fan Z, et al
    A green approach to dual-drug nanoformulations with targeting and synergistic effects for cancer therapy.
    Drug Deliv. 2017;24:51-60.
    PubMed     Text format     Abstract available

  12. YU Y, Xu S, You H, Zhang Y, et al
    In vivo synergistic anti-tumor effect of paclitaxel nanoparticles combined with radiotherapy on human cervical carcinoma.
    Drug Deliv. 2017;24:75-82.
    PubMed     Text format     Abstract available


    Eur J Cancer Prev

  13. MAURA G, Chaignot C, Weill A, Alla F, et al
    Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France: a nationwide French healthcare database study.
    Eur J Cancer Prev. 2017 Mar 31. doi: 10.1097/CEJ.0000000000000360.
    PubMed     Text format     Abstract available


    Health Policy Plan

  14. CAMPOS NG, Tsu V, Jeronimo J, Njama-Meya D, et al
    Cost-effectiveness of an HPV self-collection campaign in Uganda: comparing models for delivery of cervical cancer screening in a low-income setting.
    Health Policy Plan. 2017 Feb 20. doi: 10.1093.
    PubMed     Text format     Abstract available


    Indian J Dermatol Venereol Leprol

  15. BISHERWAL K, Pandhi D, Singal A, Guleria K, et al
    Evaluation of cervical and anal intraepithelial neoplasia in women attending a sexually transmitted infection clinic.
    Indian J Dermatol Venereol Leprol. 2016;82:498-504.
    PubMed     Text format     Abstract available


    Int J Biol Markers

  16. ROSZAK A, Lutkowska A, Lianeri M, Sowinska A, et al
    Involvement of myeloperoxidase gene polymorphism 463G>A in development of cervical squamous cell carcinoma.
    Int J Biol Markers. 2016;31:e440-e445.
    PubMed     Text format     Abstract available


    Int J Cancer

  17. BALTZER N, Sundstrom K, Nygard JF, Dillner J, et al
    Risk Stratification in Cervical Cancer Screening by Complete Screening History- Applying Bioinformatics to a General Screening Population.
    Int J Cancer. 2017 Apr 6. doi: 10.1002/ijc.30725.
    PubMed     Text format     Abstract available


    Int J Oncol

  18. ZHANG W, He W, Shi Y, Zhao J, et al
    Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
    Int J Oncol. 2016 Nov 29. doi: 10.3892/ijo.2016.3784.
    PubMed     Text format     Abstract available


    J BUON

  19. NAUMOVIC T, Lakic V, Jovicevic A, Ilic D, et al
    New software for collecting data from the organized cervical cancer screening program in Serbia. Are we on the threshold of a new screening registry? - A multicentric study.
    J BUON. 2017;22:58-63.
    PubMed     Text format     Abstract available

  20. MILENKOVIC M, Naumovic T, Perisic Z, Milenkovic D, et al
    Organised cervical cancer screening programme in the Belgrade municipality of Cukarica - Evaluation of process indicators.
    J BUON. 2017;22:44-47.
    PubMed     Text format     Abstract available


    J Cancer

  21. WANG W, Shang CL, Du QQ, Wu D, et al
    Class I versus Class III radical hysterectomy in stage IB1 (tumor </= 2 cm) cervical cancer: a matched cohort study.
    J Cancer. 2017;8:825-831.
    PubMed     Text format     Abstract available


    J Cancer Educ

  22. LAMB RL, Ramos Jaraba SM, Graciano Tangarife V, Garces-Palacio IC, et al
    Evaluation of Entertainment Education Strategies to Promote Cervical Cancer Screening and Knowledge in Colombian Women.
    J Cancer Educ. 2017 Apr 4. doi: 10.1007/s13187-017-1213.
    PubMed     Text format     Abstract available


    J Clin Diagn Res

  23. ZUTSHI V, Makkar B, Garg A, Batra S, et al
    Transvaginal Sonography Versus Cystoscopy for Detecting Urinary Bladder Invasion in Early Stage Cervical Cancer.
    J Clin Diagn Res. 2017;11:QC01-QC03.
    PubMed     Text format     Abstract available


    J Gynecol Oncol

  24. LANDONI F, Colombo A, Milani R, Placa F, et al
    Randomized study between radical surgery and radiotherapy for the treatment of stage IB-IIA cervical cancer: 20-year update.
    J Gynecol Oncol. 2017.
    PubMed     Text format     Abstract available

  25. LIM MC, Lee M, Shim SH, Nam EJ, et al
    Practice guidelines for management of cervical cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement.
    J Gynecol Oncol. 2017.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  26. KIM JJ, Burger EA, Sy S, Campos NG, et al
    Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus.
    J Natl Cancer Inst. 2017;109:1-9.
    PubMed     Text format     Abstract available


    J Obstet Gynaecol Res

  27. ANDO H, Miyamoto T, Kashima H, Takatsu A, et al
    Usefulness of a management protocol for patients with cervical multicystic lesions: A retrospective analysis of 94 cases and the significance of GNAS mutation.
    J Obstet Gynaecol Res. 2016;42:1588-1598.
    PubMed     Text format     Abstract available


    Keio J Med

  28. COLEMAN N
    Virus and Host Events in Squamous Carcinogenesis.
    Keio J Med. 2016;65:78.
    PubMed     Text format     Abstract available


    Med J Aust

  29. SMITH M, Canfell K
    Impact of the Australian National Cervical Screening Program in women of different ages.
    Med J Aust. 2016;205:359-364.
    PubMed     Text format     Abstract available

  30. CARTER J
    The renewal of the National Cervical Screening Program.
    Med J Aust. 2016;205:357-358.
    PubMed     Text format    


    Microbiol Immunol

  31. GAO J, Fan L, Ma W, Xiao H, et al
    Synergistic antitumor effect of a human papillomavirus DNA vaccine harboring E6E7 fusion gene and vascular endothelial growth factor receptor 2 gene.
    Microbiol Immunol. 2016;60:626-33.
    PubMed     Text format     Abstract available


    Mol Med Rep

  32. WANG HY, Yu HZ, Huang SM, Zheng YL, et al
    p53, Bcl-2 and cox-2 are involved in berberine hydrochloride-induced apoptosis of HeLa229 cells.
    Mol Med Rep. 2016;14:3855-61.
    PubMed     Text format     Abstract available


    Pathol Res Pract

  33. SOPRACORDEVOLE F, Clemente N, Alessandrini L, Di Giuseppe J, et al
    Detection of occult endocervical glandular dysplasia in cervical conization specimens for squamous lesions.
    Pathol Res Pract. 2017;213:210-216.
    PubMed     Text format     Abstract available


    Pathology

  34. AMYES E, Russell P, Chan F
    Cervical adenosquamous carcinoma with extension to uterine corpus.
    Pathology. 2016;48:521-3.
    PubMed     Text format    


    PLoS One

  35. GAO Q, Lin S, Bai P, Du M, et al
    FZUImageReg: A toolbox for medical image registration and dose fusion in cervical cancer radiotherapy.
    PLoS One. 2017;12:e0174926.
    PubMed     Text format     Abstract available

  36. LABEIT AM, Peinemann F
    Determinants of a GP visit and cervical cancer screening examination in Great Britain.
    PLoS One. 2017;12:e0174363.
    PubMed     Text format     Abstract available


    Radiother Oncol

  37. VAN HEERDEN LE, Houweling AC, Koedooder K, van Kesteren Z, et al
    Structure-based deformable image registration: Added value for dose accumulation of external beam radiotherapy and brachytherapy in cervical cancer.
    Radiother Oncol. 2017 Mar 31. pii: S0167-8140(17)30111.
    PubMed     Text format     Abstract available


    Reprod Sci

  38. CHEN TH, Yang SF, Liu YF, Lin WL, et al
    Association of Fibroblast Growth Factor Receptor 4 Genetic Polymorphisms With the Development of Uterine Cervical Cancer and Patient Prognosis.
    Reprod Sci. 2017 Jan 1:1933719117702250. doi: 10.1177/1933719117702250.
    PubMed     Text format     Abstract available


    Sci Rep

  39. YUAN H, Krawczyk E, Blancato J, Albanese C, et al
    HPV positive neuroendocrine cervical cancer cells are dependent on Myc but not E6/E7 viral oncogenes.
    Sci Rep. 2017;7:45617.
    PubMed     Text format     Abstract available


    Singapore Med J

  40. ZHUANG QY, Wong RX, Chen WM, Guo XX, et al
    Knowledge, attitudes and practices regarding human papillomavirus vaccination among young women attending a tertiary institution in Singapore.
    Singapore Med J. 2016;57:329-33.
    PubMed     Text format     Abstract available


    Tumour Biol

  41. CHEN X, Lan K, Liu Q, Yang X, et al
    Sulfiredoxin may promote metastasis and invasion of cervical squamous cell carcinoma by epithelial-mesenchymal transition.
    Tumour Biol. 2017;39:1010428317695942.
    PubMed     Text format     Abstract available

  42. YANG H, Yang M, Wang Y, Huang X, et al
    Note of clarification of data in the paper entitled "Interferon gamma +874 T/A polymorphism increases the risk of cervical cancer: evidence from a meta-analysis".
    Tumour Biol. 2017;39:1010428317694564.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: